Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01989546
Title Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

pancreatic cancer

stomach cancer

prostate cancer

ovarian cancer

peritoneum cancer

breast cancer

Advanced Solid Tumor

Therapies

Talazoparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.